abstract |
The present invention relates to recombinant, mutant Candida utilis uricase enzymes having improved stability and / or activity of pancreatin, compositions containing such uricase enzymes, which can be used, inter alia, to treat diseases. or disorders associated with high levels of uric acid, including, for example, hyperuricemia, hyperuricosuria and gout. |